Reply: Atypical Antipsychotics Mechanisms of Action

Seeman P. Atypical antipsychotics: Mechanism of action. Can J Psychiatry 2002;47:27–38.

Seeman P Tallerico T. Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. Mol Psychiatry 1998;3:123–34.

Seeman P Tallerico T. Rapid release of antipsychotic drugs from dopamine D2 receptors: An explanation for low receptor occupancy and early clinical relapse upon drug withdrawal of clozapine or quetiapine. Am J Psychiatry 1999;156:876–84.

Kapur S Seeman P. Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?—a new hypothesis. Am J Psychiatry 2001;158:360–9.

Kapur S Seeman P. Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. J Psychiatry Neurosci 2000;25:161–6.

Kapur S Zipursky R Jones C Shammi CS Remington G Seeman P. A positron emission tomography study of quetiapine in schizophrenia—a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psychiatry 2000;57:553–9.

Kapur S Seeman P Zipursky R Remington GJ . Fast dissociation from the dopamine D2 receptor (not high affinity at multiple receptors) is the key to “atypical” antipsychotics. Schizophr Res 2001;49(1,2 Suppl):92.

Kapur S McClelland RA Vanderspeck SC Wadenberg M-L Baker G Nobrega J , and others. Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic action. Neuroreport 2002;13:831–5.

Vanderspeck SC Brownlee BA Nobrega J McClelland R Seeman P Kapur S. Converting a typical antipsychotic into an atypical one—the critical role of D2. Schizophr Res 2003. Forthcoming.

Sa DS Kapur S Lang AE . Amoxapine shows an antipsychotic effect but worsens motor function with Parkinson's disease and psychosis. Clin Neuropharmacol 2001;24:242–4.

Hornykiewicz O. Chemical neuroanatomy of the basal ganglia normal and in Parkinson's disease. J Chem Neuroanat 2001;22:3–12.

Kapur S Cho R Jones C McKay G Zipursky RB . Is amoxapine an atypical antipsychotic? Positronemission tomography investigation of its dopamine2 and serotonin2 occupancy. Biol Psychiatry 1999;45:1217–20.

Goetz CG Blasucci LM Leurgans S Pappert EJ . Olanzapine and clozapine: Comparative effects on motor function in hallucinating PD patients. Neurology 2000;55:789–94.

Friedman JH Factor SA . Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 2000;15:201–11.

Alfaro CL Wudarsky M Nicolson R Gochman P Sporn A Lenane M Rapoport JL . Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine. J Child Adolesc Psychopharmacol 2002;12:83–91.

Markianos M Hatzimanolis J Lykouras L Christodoulou GN . Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treament with clozapine or with olanzapine. Schizophr Res 2002;56:11–7.

Kapur S Langlois X Vinken P Megens AAHP De Coster R Andrews JS . The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood–brain disposition: A pharmacological analysis in rats. J Pharmacol Exp Ther 2002;302:1129–34.

Sultana A Reilly J Fenton M. Thioridazine for schizophrenia. Cochrane Database Syst Rev 2000;CD001944.

Crowley TJ Hydinger-Macdonald M. Motility, parkinsonism, and prolactin with thiothixene and thioridazine. Arch Gen Psychiatry 1981;38:668–75.

Laduron PM Leysen JE . Is the low incidence of extrapyramidal side-effects of antipsychotics associated with anti-muscarinic properties? J Pharm Pharmacol 1978;30:120–2.

Bolden C Cusack B Richelson E. Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells. Eur J Pharmacol 1991;192:205–6.

Zorn SH Jones SB Ward KM Liston DR . Clozapine is a potent and selective muscarinic M4 receptor agonist. Eur J Pharmacol 1994;269:R1–R2.

Suhara T Okubo Y Yasuno F Sudo Y Inoue M Ichimiya T , and others. Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Arch Gen Psychiatry 2002;59:25–30.

Shaw P Pilowsky LS . Probing cortical sites of antipsychotic drug action with in vivo receptor imaging. Behav Neurol 2000;12:3–9.